# A Heart Under Stress: Anaesthetic Strategy for a Pregnant Patient With Long QT Syndrome

**Authors:** Maria J Nascimento, Marta Silva, Ana Bernardino, Joana Carvalhas

PMC · DOI: 10.7759/cureus.100633 · Cureus · 2026-01-02

## TL;DR

This paper discusses the safe anesthetic management of a pregnant woman with Long QT Syndrome during a caesarean section.

## Contribution

The paper presents a novel anaesthetic strategy for managing LQTS1 patients during childbirth.

## Key findings

- Total intravenous anaesthesia with propofol and remifentanil was safely used in a high-risk LQTS1 patient.
- Multidisciplinary planning and monitoring minimized arrhythmic risks during the procedure.
- Electrolyte optimization and sympathetic control were critical for successful outcomes.

## Abstract

Long QT syndrome (LQTS) is a cardiac channelopathy associated with a high risk of malignant arrhythmias. Hormonal changes during pregnancy, especially in the peripartum period, increase the risk of adverse cardiac events in women with LQTS. Anaesthetic management in these patients is challenging, as there are no established guidelines and most anaesthetic agents prolong the QT interval.

This report describes the anaesthetic management of an elective caesarean section in a 34-year-old pregnant woman, 35 weeks pregnant, with congenital LQTS type 1 (LQTS1), a corrected QT interval (QTc) of 597 milliseconds (ms) on the admission day, and a high cardiovascular risk. Given the high arrhythmic risk, perioperative planning and management were undertaken by a multidisciplinary team to optimise patient outcomes and minimise risks. Total intravenous anaesthesia with propofol and remifentanil was used, alongside strict electrolyte optimisation, sympathetic control, and continuous advanced monitoring.

Careful perioperative planning and appropriate monitoring can enable the safe use of general anaesthesia for caesarean section in selected women with LQTS1.

## Linked entities

- **Chemicals:** propofol (PubChem CID 4943), remifentanil (PubChem CID 60815)
- **Diseases:** Long QT syndrome (MONDO:0002442)

## Full-text entities

- **Diseases:** LQTS1 (MESH:D029597), malignant arrhythmias (MESH:D001145), LQTS (MESH:D008133), cardiac channelopathy (MESH:D053447), arrhythmic (OMIM:212500)
- **Chemicals:** propofol (MESH:D015742), remifentanil (MESH:D000077208)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12861341/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12861341/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12861341/full.md

---
Source: https://tomesphere.com/paper/PMC12861341